| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/13/2004 | WO2003080022A3 Analgesics for nasal administration |
| 05/13/2004 | WO2003077831A3 Compositions and methods for treating mdma-induced toxicity |
| 05/13/2004 | WO2003077830A3 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 05/13/2004 | WO2003070280A3 Absorption enhancing agent |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2003061572A3 Anti-inflammatory formulations |
| 05/13/2004 | WO2003059194A3 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003045977A3 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes |
| 05/13/2004 | WO2003045420A3 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 05/13/2004 | WO2003039475A8 Methods of identifying and using modulators of fractalkine receptor |
| 05/13/2004 | WO2003037337A8 Depot formulations of iloperidone and a star polymer |
| 05/13/2004 | WO2003037291A8 Cream for treatment of skin injured by the sun |
| 05/13/2004 | WO2003035000A3 Method for treating non-neuropathic pain |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003033657A3 Antisense antiviral agent and method for treating ssrna viral infection |
| 05/13/2004 | WO2003020208A3 Treatment of neurologic hemorrhage |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2003015695B1 Canine cardiac diet |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | WO2002102804A8 New use of specific cyclolignans |
| 05/13/2004 | WO2002085447A8 Microprojection array having a beneficial agent containing coating |
| 05/13/2004 | WO2002072073A3 Pharmaceutical formulation comprising atorvastatin calcium |
| 05/13/2004 | WO2002064735A3 Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 |
| 05/13/2004 | WO2002056903A9 Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators |
| 05/13/2004 | WO2002055013A8 Therapeutic chromone compounds |
| 05/13/2004 | WO2002051387A8 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 05/13/2004 | WO2002047703A8 Immune system stimulation |
| 05/13/2004 | WO2002024146A9 Methods of decreasing or preventing pain using spicamycin derivatives |
| 05/13/2004 | US20040093079 Compositions and methods for the reduction of post-angioplasty stenosis |
| 05/13/2004 | US20040092771 Nitro-benzamide useful as anti-arrhythmic agent |
| 05/13/2004 | US20040092749 Polysubstituted idan-1-ol compounds, and methods for their preparation and use |
| 05/13/2004 | US20040092748 Carbocyclic esters such as 5-chloro-2-methanesulfonylindan-1--yl-4-chlorobenzoate, used as anorexigenic agents; dietetics |
| 05/13/2004 | US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092744 Process for preparing crystalline form I of cabergoline |
| 05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 05/13/2004 | US20040092736 Collections of compounds |
| 05/13/2004 | US20040092730 Hepatitis C virus non-structural NS3/4A fusion gene |
| 05/13/2004 | US20040092729 Oligonucleotide sequences coding genetic suppressor elements resistant to antitumor agents; multidrug resistance in cancer cells |
| 05/13/2004 | US20040092727 Cochleates without metal cations as bridging agents |
| 05/13/2004 | US20040092605 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 05/13/2004 | US20040092604 Amino-tetralin derivatives as muscarinic receptor antagonists |
| 05/13/2004 | US20040092603 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties |
| 05/13/2004 | US20040092602 Method for treatment and chemoprevention of prostate cancer |
| 05/13/2004 | US20040092601 Sustained released form |
| 05/13/2004 | US20040092600 Novel sphingolipid synthesis inhibitor |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092597 Fenofibrate compositions having high bioavailability |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092595 Analgesic agent |
| 05/13/2004 | US20040092594 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 05/13/2004 | US20040092593 Hypotensive agents; cardiovascular disorders |
| 05/13/2004 | US20040092591 Fibromyalgia therapy; anticonvulsants; antiepileptic agents; neurodegradation diseases; antiarthritic agents |
| 05/13/2004 | US20040092590 Glycemic control for prediabetes and/or diabetes Type II using docosahexaenoic acid |
| 05/13/2004 | US20040092589 Cognition activators; administering retinoic acid as cis configuration |
| 05/13/2004 | US20040092587 Freeze-dried preparation of n[o-(p-pivaloyloxybenzenesulfonylamino) benzoyl] glycine monosodium salt tetrahydrate and process for producing the same |
| 05/13/2004 | US20040092586 Oxidation resistance; aging resistance; skin disorders |
| 05/13/2004 | US20040092584 Sensitizing cells to radiation; anticancer agents |
| 05/13/2004 | US20040092583 Treatment for inhibiting neoplastic lesions |
| 05/13/2004 | US20040092582 Antiinflammatory agents; respiratory system disorders; antiarthritic agents; autoimmune diseases; antidiabetic agents |
| 05/13/2004 | US20040092580 Antitumor agents; anticancer agents |
| 05/13/2004 | US20040092578 Inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 05/13/2004 | US20040092577 In situ insertion of paclitaxel; powder regenerated as injection |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092575 Prevent insertion of peptide into cell membranes |
| 05/13/2004 | US20040092574 Statin-Lp(a) inhibitor combinations |
| 05/13/2004 | US20040092571 Antilipemic agents; anticholesterol agents; synergistic mixtures of n-(1-octyl-5-carboxy-4,6-dimethylinsol-7-yl)-2,2-dimethylpropanamide compound and enzyme inhibitor |
| 05/13/2004 | US20040092570 Analgesics |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092568 Administering kinase inhibitor |
| 05/13/2004 | US20040092567 Cardiovascular disorders; hypotensive agents |
| 05/13/2004 | US20040092565 Synergistic mixture; anticancer agents; enhance penetration of cancer cells |
| 05/13/2004 | US20040092564 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092563 Angiotensin II antagonists |
| 05/13/2004 | US20040092562 Methods for treating inflammatory conditions or inhibiting JNK |
| 05/13/2004 | US20040092558 Antiemetic agents; vision disorders |
| 05/13/2004 | US20040092557 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/13/2004 | US20040092556 Aids therapy |
| 05/13/2004 | US20040092555 Pharmaceutical compositions of a thiazolidinedione derivative and their use as antidiabetics |
| 05/13/2004 | US20040092554 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists |
| 05/13/2004 | US20040092551 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092550 Anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092549 Methods and compositions for selective cancer chemotherapy |
| 05/13/2004 | US20040092546 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
| 05/13/2004 | US20040092544 Synergistic mixture containing dopamine agent; muscular disorders; analgesics |
| 05/13/2004 | US20040092543 Phospholipase inhibitors; antiinflammatory agents; sepsis shock |
| 05/13/2004 | US20040092542 Tamper-resistant oral opioid agonist formulations |
| 05/13/2004 | US20040092540 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
| 05/13/2004 | US20040092537 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy |
| 05/13/2004 | US20040092536 Side effect reduction; muscular disorders; trauma |
| 05/13/2004 | US20040092535 Anticancer agents; antidiabetic agents; Alzheimer's disease; autoimmune disease |
| 05/13/2004 | US20040092534 Orally administering a capsule shaped tablet core dosage form containing paliperidone, releases paliperidone an ascending release rate form a prolonged period of time |
| 05/13/2004 | US20040092533 Central nervous system disorders; anxiolytic agents; anticonvulsants; cognition activators; side effect reduction |
| 05/13/2004 | US20040092532 Use of p38 inhibitors for the treatment of smoke inhalation |
| 05/13/2004 | US20040092531 Active substance combination containing an opioid having a fentanyl-type structure and ketamine |
| 05/13/2004 | US20040092530 Administering mixture of alanine and serine |
| 05/13/2004 | US20040092529 Immunology moderator; Alzheimer's disease; anticancer agents; antiinflamamtory agents |